首页TMCI • NASDAQ
add
Treace Medical Concepts Inc
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 4508.60万 | 10.62% |
经营支出 | 5126.60万 | 1.36% |
净收入 | -1536.00万 | 12.33% |
净利润率 | -34.07 | 20.75% |
每股收益 | -0.25 | 10.71% |
息税折旧摊销前利润 | -1297.70万 | 20.16% |
有效税率 | — | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 8279.90万 | -32.22% |
总资产 | 2.13亿 | -11.41% |
负债总额 | 1.08亿 | 5.38% |
权益总额 | 1.05亿 | — |
发行在外的股份 | 6229.71万 | — |
市净率 | 4.93 | — |
资产回报率 | -17.24% | — |
资本回报率 | -21.19% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -1536.00万 | 12.33% |
来自运营的现金 | -1184.20万 | -24.48% |
投资现金 | 576.30万 | 25.36% |
融资现金 | 8000.00 | -94.97% |
现金净变动 | -607.10万 | -27.62% |
自由现金流 | -750.14万 | 37.82% |
简介
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
成立时间
2014
员工数量
516
